- Research article
- Open Access
Naturally occurring antisense RNA of histone H2a in mouse cultured cell lines
© Nishida et al; licensee BioMed Central Ltd. 2005
- Received: 01 December 2004
- Accepted: 14 May 2005
- Published: 14 May 2005
An antisense transcript of histone H2a that has no significant protein-coding region has been cloned from a mouse full-length cDNA library. In the present study, we evaluated this transcript by using RT-PCR and compared the expression patterns of the sense and antisense transcripts by using quantitative RT-PCR (qRT-PCR).
This antisense RNA was expressed in three mouse cell lines. We call it ASH2a. ASH2a includes not only the complementary sequence of the transcript of Hist2h2aa2 (a replication-dependent histone H2a gene), but also that of the promoter of Hist2h2aa2. The upstream genomic sequence of the transcription start site of the ASH2a-coding gene (ASH2a) lacks both CCAAT and TATA boxes. This absence suggests that the regulation of ASH2a is different from that of the replication-dependent histone H2a genes. Findings from qRT-PCR indicated that the expression pattern of ASH2a was different from that of Hist2h2aa2. Expression of Hist2h2aa2 peaked at 2 to 4 h during S-phase, but that of ASH2a peaked at 1 h.
We showed the existence of ASH2a, a histone H2a antisense RNA, in mouse cultured cells. The expression pattern of ASH2a is different from that of the sense RNA.
- Antisense Transcript
- Murine Hepatoma Cell
- Hexamer Oligonucleotide
- Accession Number AK028129
- Upstream Genomic Sequence
A comprehensive search of the Functional Annotation of Mouse (FANTOM) database revealed about 30000 full-length cDNA clones without a significant protein-coding region . Indeed, antisense transcripts seem to be present in 10% to 20% of genes in human and mouse genomes [2–6]. These findings suggest that many biological reactions related to antisense transcripts and/or protein-noncoding transcripts are still unrevealed . On the other hand, the cDNA database sometimes includes reverse complements of real transcripts. These artifacts are excluded from the database on the basis of the sequences of intron-splicing sites. Therefore, transcripts without any introns need more experimental evaluation than computational annotation to ascertain their validity.
Histone mRNAs regulated by the cell cycle increase at the beginning of S-phase and decrease at the end of S-phase . Among 20 histone H2a-coding genes, 18 are replication-dependent; the other 2 are replication-independent . The replication-dependent genes lack introns and a poly (A) signal and contain a highly conserved stem-loop structure at the 3' end of the mRNA. This stem-loop structure plays an important role in mRNA processing and stability [10–12]. The promoters of the replication-dependent histone genes contain CCAAT and TATA boxes .
As far as we know, Drosophila histone H3 antisense  and Leishmania histone H1 antisense  transcripts have been reported, but no histone H2a antisense RNA or mammalian histone antisense RNA has been reported. FANTOM 2  contains an antisense transcript (FANTOM clone ID 2210403F13; accession number AK028129) of histone H2a. We call this antisense transcript ASH2a. Comparison of the nucleotide sequence of ASH2a and the mouse genome sequence showed that the ASH2a-coding gene (ASH2a) lies on chromosome 6 without introns. The sequence of ASH2a is exactly complementary to that of the coding region of Hist2h2aa2 (a replication-dependent histone H2a gene) and that of the promoter. In the present study, we evaluated ASH2a transcript by using RT-PCR and compared the expression patterns of Hist2h2aa2 and ASH2a by using qRT-PCR.
Detection of ASH2a
Second, to elucidate the expression of ASH2a, we transcribed the first-strand cDNA with primer R3, which hybridizes specifically to ASH2a. A product of the expected size (685 bp) was obtained (Fig. 2c). In addition, Eco RI digested the PCR product to 269- and 416-bp fragments (Fig. 2c). These results are consistent with the nucleotide sequence of ASH2a.
An antisense transcript of histone H2a (ASH2a) was clearly expressed in three mouse cell lines, Hepa 1–6, 3T3, and LLC. This result strongly suggests that ASH2a is not regulated with tissue specificity. We checked the upstream regions of ASH2a and the promoter regions of mouse histone H2a genes. All promoters of replication-dependent histone H2a genes include CCAAT and TATA boxes . On the other hand, the upstream region of ASH2a lacks such a structure (Fig. 1). This region has a G+C-rich sequence but lacks both CCAAT and TATA boxes (Fig. 1). Therefore, the regulation of ASH2a is strongly suggested to be different from those of replication-dependent histone H2a genes.
To check the synchronization of the cells, we compared the expression patterns of the replication-dependent histone gene Hist2h2aa2 and the replication-independent histone gene H2afz . Hepa 1–6 cells used in the present study were well synchronized. In fact, the expression pattern of ASH2a was different from that of Hist2h2aa2. The amount of sense RNA was always much higher than that of ASH2a RNA at each time point. Three general functions of antisense transcripts have been identified: transcriptional interference, RNA masking, and dsRNA-dependent mechanisms, including RNA interference . These functions are related to inhibition and/or degradation of sense RNAs. If ASH2a is related to the degradation of the sense RNA through dsRNA formation, ASH2a would be expressed when the sense RNA decreases. However, ASH2a is expressed during the early increase of the sense RNA.
On the other hand, ASH2a could hybridize not only to the Hist2h2aa2 transcript, but also to the transcripts of the other histone H2a-coding genes, because of the high similarity of protein coding sequences. A recent article showed that a small modulatory dsRNA can function as an activator of related genes , and the mechanism of action appears to be mediated through a dsRNA/protein interaction, rather than through siRNA or miRNA. Interestingly, ASH2a includes not only a sequence complementary to that of the Hist2h2aa2 transcript, but also a sequence complementary to the promoter region of Hist2h2aa2. Additional work is needed to elucidate the function of the ASH2a-related dsRNA.
Experiments using the high-density oligonucleotide arrays show that a large population of noncoding RNAs are expressed and regulated by similar molecular mechanisms to those involved in the control of protein-coding RNAs  and that many transcripts appear to be at very low abundance . It is so important for genome research to elucidate the functions and regulation of noncoding RNAs and antisense RNAs at very low abundance such as ASH2a.
Murine hepatoma cell line Hepa 1–6, fibroblast cell line Flp-In-3T3 (Invitrogen), and lung carcinoma cell line LLC were cultured in DMEM supplemented with 10% fetal calf serum.
Cell cycle synchronization
Hepa 1–6 cells were synchronized at the end of G1 phase by the addition of thymidine-hydroxyurea. The cell cycle arrest was released by washing out the thymidine-hydroxyurea, then the cells were harvested at intervals of 1 h from 0 h to 12 h.
Total RNA fractions extracted from mouse cells were pre-treated with DNase I and used for RT-PCR. Reaction mixture containing the RNA (approximately 0.5 μg) and the strand-specific primer (3.3 pmol) or random hexamer primers was denatured at 70°C, and then reverse-transcription reaction was done with Superscript III (Invitrogen) according to the manual. Then the cDNA was amplified by PCR under the condition of 35 or 40 cycles of 30 s at 95°C, 30 s at 54°C, and 1 or 2 min at 72°C. The sequences of primers are shown in Fig. 1. For quantitative RT-PCR (qRT-PCR), approximately 12.5 ng of total RNA was used for reverse transcription followed by PCR amplification with primers qF1 and R1, or qF2 and R2 (Fig. 1) in reaction mixture containing SYBR premix Ex Taq (Takara) in an ABI PRISM 7700 sequence detection system (Applied Biosystems). The PCR conditions were an initial step of 30 s at 95°C, followed by 40 cycles of 5 s at 95°C and 30 s at 60°C. Expression was assessed by evaluating threshold cycle (CT) values. The relative amount of expressed RNA was calculated using Livak and Schmittgen's method . Quantification of GAPDH (glyceraldehyde-3-phosphate dehydrogenase) mRNA (primers 5'-TGTGTCCGTCGTGGATCTGA-3' and 5'-CCTGCTTCACCACCTTCTTGA-3'; product size 76 bp) was used as a control for data normalization. The qRT-PCR analyses were performed four times.
We thank the anonymous reviewer for their helpful comments. We are grateful to Yap Chan Choo, Misato Nakanishi, Taku Tanaka, and Masanori Suzuki for helpful comments. This work was supported in part by a Research Grant for the RIKEN Genome Exploration Research Project, a Research Grant for Advanced and Innovational Research Program in Life Science, and a Research Grant for the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the Japanese Government, and in part by a Research Grant for CREST of Japan Science and Technology Corporation to Y.H., and supported in part by grant 15770055 from the MEXT to H.N.
- Okazaki Y, Furuno M, Kasukawa T, Adachi J, Bono H, Kondo S, Nikaido I, Osato N, Saito R, Suzuki H, Yamanaka I, Kiyosawa H, Yagi K, Tomaru Y, Hasegawa Y, Nogami A, Schonbach C, Gojobori T, Baldarelli R, Hill DP, Bult C, Hume DA, Quackenbush J, Schriml LM, Kanapin A, Matsuda H, Batalov S, Beisel KW, Blake JA, Bradt D, Brusic V, Chothia C, Corbani LE, Cousins S, Dalla E, Dragani TA, Fletcher CF, Forrest A, Frazer KS, Gaasterland T, Gariboldi M, Gissi C, Godzik A, Gough J, Grimmond S, Gustincich S, Hirokawa N, Jackson IJ, Jarvis ED, Kanai A, Kawaji H, Kawasawa Y, Kedzierski RM, King BL, Konagaya A, Kurochkin IV, Lee Y, Lenhard B, Lyons PA, Maglott DR, Maltais L, Marchionni L, McKenzie L, Miki H, Nagashima T, Numata K, Okido T, Pavan WJ, Pertea G, Pesole G, Petrovsky N, Pillai R, Pontius JU, Qi D, Ramachandran S, Ravasi T, Reed JC, Reed DJ, Reid J, Ring BZ, Ringwald M, Sandelin A, Schneider C, Semple CA, Setou M, Shimada K, Sultana R, Takenaka Y, Taylor MS, Teasdale RD, Tomita M, Verardo R, Wagner L, Wahlestedt C, Wang Y, Watanabe Y, Wells C, Wilming LG, Wynshaw-Boris A, Yanagisawa M, Yang I, Yang L, Yuan Z, Zavolan M, Zhu Y, Zimmer A, Carninci P, Hayatsu N, Hirozane-Kishikawa T, Konno H, Nakamura M, Sakazume N, Sato K, Shiraki T, Waki K, Kawai J, Aizawa K, Arakawa T, Fukuda S, Hara A, Hashizume W, Imotani K, Ishii Y, Itoh M, Kagawa I, Miyazaki A, Sakai K, Sasaki D, Shibata K, Shinagawa A, Yasunishi A, Yoshino M, Waterston R, Lander ES, Rogers J, Birney E, Hayashizaki Y: Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature. 2002, 420: 563-573. 10.1038/nature01266.View ArticlePubMedGoogle Scholar
- Herbert A: The four Rs of RNA-directed evolution. Nature Genet. 2004, 36: 19-25. 10.1038/ng1275.View ArticlePubMedGoogle Scholar
- Kiyosawa H, Yamanaka I, Osato N, Kondo S, Hayashizaki Y: Antisense transcripts with FANTOM2 clone set and their implications for gene regulation. Genome Res. 2003, 13: 1324-1334. 10.1101/gr.982903.PubMed CentralView ArticlePubMedGoogle Scholar
- Shendure J, Church GM: Computational discovery of sense-antisense transcription in the human and mouse genomes. Genome Biol. 2003, 3: research0044.1-0044.14. 10.1186/gb-2002-3-9-research0044.Google Scholar
- Yelin R, Dahary D, Sorek R, Levanon EY, Goldstein O, Shoshan A, Diber A, Biton S, Tamir Y, Khosravi R, Nemzer S, Pinner E, Walach S, Bernstein J, Savitsky K, Rotman G: Widespread occurrence of antisense transcription in the human genome. Nat Biotechnol. 2003, 21: 379-386. 10.1038/nbt808.View ArticlePubMedGoogle Scholar
- Carmichael GG: Antisense starts making more sense. Nat Biotechnol. 2003, 21: 371-372. 10.1038/nbt808.View ArticlePubMedGoogle Scholar
- Mattick JS: RNA regulation: a new genetics?. Nat Rev Genet. 2004, 5: 316-323. 10.1038/nrg1321.View ArticlePubMedGoogle Scholar
- Harris ME, Böhni R, Schneiderman MH, Ramamurthy L, Schümperli D, Marzluff WF: Regulation of histone mRNA in the unperturbed cell cycle: evidence suggesting control at two posttranscriptional steps. Mol Cell Biol. 1991, 11: 2416-2424.PubMed CentralView ArticlePubMedGoogle Scholar
- Marzluff WF, Gongidi P, Woods KR, Jin J, Maltais LJ: The human and mouse replication-dependent histone genes. Genomics. 2002, 80: 487-498. 10.1016/S0888-7543(02)96850-3.View ArticlePubMedGoogle Scholar
- Dominski Z, Marzluff WF: Formation of the 3' end of histone mRNA. Gene. 1999, 239: 1-14. 10.1016/S0378-1119(99)00367-4.View ArticlePubMedGoogle Scholar
- Graves RA, Pandey NB, Chodchoy N, Marzluff WF: Translation is required for regulation of histone mRNA degradation. Cell. 1987, 48: 615-626. 10.1016/0092-8674(87)90240-6.View ArticlePubMedGoogle Scholar
- Lanzotti DJ, Kaygum H, Yang X, Duronin RJ, Marzluff WF: Developmental control of histone mRNA and dSLBP synthesis during Drosophila embryogenesis and the role of dSLBP in histone mRNA 3' processing in vivo. Mol Cell Biol. 2002, 22: 2267-2282. 10.1128/MCB.22.7.2267-2282.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- Osley MA: The regulation of histone synthesis in the cell cycle. Annu Rev Biochem. 1991, 60: 827-861. 10.1146/annurev.bi.60.070191.004143.View ArticlePubMedGoogle Scholar
- Akhmanova A, Kremer H, Miedema K, Hennig W: Naturally occurring testis-specific histone H3 antisense transcripts in Drosophila. Mol Reprod Dev. 1997, 48: 413-420. 10.1002/(SICI)1098-2795(199712)48:4<413::AID-MRD1>3.0.CO;2-T.View ArticlePubMedGoogle Scholar
- Belli SI, Monnerat S, Schaff C, Masina S, Noll T, Myler PJ, Stuart K, Fasel N: Sense and antisense transcripts in the histone H1 (HIS-1 locus of Leishmania major. Int J Parasitol. 2003, 33: 965-975. 10.1016/S0020-7519(03)00126-7.View ArticlePubMedGoogle Scholar
- Nishida H, Suzuki T, Tomaru Y, Hayashizaki Y: A novel replication-independent histone H2a gene in mouse. BMC Genetics. 2005, 6: 10-10.1186/1471-2156-6-10.PubMed CentralView ArticlePubMedGoogle Scholar
- Lavorgna G, Dahary D, Lehner B, Sorek R, Sanderson CM, Casari G: In search of antisense. Trends Biochem Sci. 2004, 29: 88-94. 10.1016/j.tibs.2003.12.002.View ArticlePubMedGoogle Scholar
- Kuwabara T, Hsieh J, Nakashima K, Taira K, Gage FH: A small modulatory dsRNA specifies the fate of adult neural stem cells. Cell. 2004, 116: 779-793. 10.1016/S0092-8674(04)00248-X.View ArticlePubMedGoogle Scholar
- Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, Kampa D, Piccolboni A, Sementchenko V, Cheng J, Williams AJ, Wheeler R, Wong B, Drenkow J, Yamanaka M, Patel S, Brubaker S, Tammana H, Helt G, Struhl K, Gingeras TR: Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell. 2004, 116: 499-509. 10.1016/S0092-8674(04)00127-8.View ArticlePubMedGoogle Scholar
- Kampa D, Cheng J, Kapranov P, Yamanaka M, Brubaker S, Cawley S, Drenkow J, Piccolboni A, Bekiranov S, Helt G, Tammana H, Gingeras TR: Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. Genome Res. 2004, 14: 331-342. 10.1101/gr.2094104.PubMed CentralView ArticlePubMedGoogle Scholar
- Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.